Q32 Bio Inc.
QTTB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $24 | $18 | $20 | $42 |
| - Cash | $49 | $55 | $65 | $78 |
| + Debt | $11 | $19 | $19 | $19 |
| Enterprise Value | -$13 | -$18 | -$27 | -$17 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7 | -$9 | -$11 | $7 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$9 | -$11 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.6 | -0.78 | -0.9 | -1.16 |
| % Growth | 23.1% | 13.3% | 22.4% | – |
| Operating Cash Flow | -$4 | -$11 | -$12 | -$11 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$4 | -$11 | -$12 | -$11 |